Prostate Cancer Drug Improves Survival
Dendreon said its prostate cancer treatment Provenge prolonged patient survival, providing fuel for a rally in its shares.
Video Rating: 5 / 5
JJ Santoro — Prostate Cancer Survivor
www.cancercenter.com JJ Santoro recalls his diagnosis with an aggressive stage prostate cancer and his frustration with his local healthcare provider. JJ says of Cancer Treatment Centers of America (CTCA), “They found more in three days than the others did in seven months. They came up with a game plan. They… Continue reading
Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone
Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone
Following recent FDA approvals for prostate cancer treatment medications from Dendreon and Sanofi-Aventis, a new study shows that the lives of men with advanced prostate cancer were prolonged almost four months on Abiraterone, a new medication from… Continue reading
USMD Prostate Cancer Center | CBS11 DFW
Story on the brand-new USMD Prostate Cancer Center at USMD Hospital in Arlington – one of the world’s most comprehensive prostate cancer diagnosis and treatment centers. Covered by CBS 11 in Dallas/Fort Worth!
Video Rating: 5 / 5
Bodybuilding and Effects Upon the Prostate
Bodybuilding and Effects Upon the Prostate
Normal 0
Ask any teenager the effects of steroids, and his mainstream media brainwashing will likely cause him to respond with the three most commonly cited side effects. The first side effect mentioned will likely be liver damage. We all know that injectables don’t… Continue reading
Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection In Second-Line Advanced Prostate Cancer …
Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection In Second-Line Advanced Prostate Cancer …
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana® (cabazitaxel) Injection,… Continue reading